go seek
5 minutes ago
Evolus reports that the toxin market is strong and continues to grow. In a comparison of marketing capabilities, Evolus vs Revance, it appears Evolus has superior marketing capabilities. IMO, DAXXIFY should gradually gain market share vs competitors with increased patient experience over time.